Back
Greenlight Capital Re Vs. Nukkleus Industry Stock Comparison
Buy
60
GLRE
Greenlight Capital Re
Last Price:
$13.84
Seasonality Move:
2.45%
Sell
46
NUKK
Nukkleus
Last Price:
$40.15
Seasonality Move:
-21.57%
Buy
60
Greenlight Capital Re (GLRE)
is a Buy
Is Greenlight Capital Re a Buy, Sell or Hold?
-
The current Greenlight Capital Re [GLRE] share price is $13.90. The Score for GLRE is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
GLRE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
46
Nukkleus (NUKK)
is a Sell
Is Nukkleus a Buy, Sell or Hold?
-
NUKK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GLRE Stock Price Chart
What is Greenlight Capital Re's stock price today?
-
The Greenlight Capital Re share price today is $13.90Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GLRE is experiencing slight buying pressure.
NUKK Stock Price Chart
GLRE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.11 | Sell |
Relative Strength Index (14 RSI): | 30.72 | Sell |
Chaikin Money Flow: | 48947 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (14.37 - 15.09) | Sell |
Bollinger Bands (100): | (13.22 - 14.62) | Sell |
NUKK Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 8.69 | Buy |
Relative Strength Index (14 RSI): | 77.28 | Buy |
Chaikin Money Flow: | -1366926 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (-7.5 - 22.6) | Buy |
Bollinger Bands (100): | (-4.22 - 11.5) | Buy |
GLRE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 14.39 | Sell |
20-day SMA: | 14.74 | Sell |
50-day SMA: | 14.33 | Sell |
200-day SMA: | 13.3 | Buy |
8-day EMA: | 14.28 | Sell |
20-day EMA: | 14.52 | Sell |
50-day EMA: | 14.37 | Sell |
200-day EMA: | 13.34 | Buy |
NUKK Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 20.07 | Buy |
20-day SMA: | 9 | Buy |
50-day SMA: | 4.99 | Buy |
200-day SMA: | 4.78 | Buy |
8-day EMA: | 26.51 | Buy |
20-day EMA: | 14.21 | Buy |
50-day EMA: | 7.47 | Buy |
200-day EMA: | 11.77 | Buy |
Greenlight Capital Re Earnings Growth & GLRE Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Nukkleus Earnings Growth & NUKK Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Greenlight Capital Re Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Nukkleus Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |